| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Grp Pres-global Business | Group Pres, Global Diagnostics | Div. President, Diagnostics
2 companies
Thornal Kevin R is a Group Pres, Global Diagnostics at HOLX, with reported holdings spanning 2 companies. Recent filings cover 0 purchases and 6 sales. Those positions are worth an estimated $4.7M at current prices.
Thornal Kevin R's largest disclosed position is in HOLX as Group Pres, Global Diagnostics, worth about $4.7M. The recent filings there lean toward selling, a net 49,875 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | ZBH Zimmer Biomet Holdings, Inc. | Grp Pres-global Business | Sell | 5,691 | $92.95 | $528,978.45 | -100% | - | - | |
| Nov 15, 2022 | HOLX Hologic Inc | Group Pres, Global Diagnostics | Sale+OE | 19,118 | $75.32 | $1,440,061.85 | -23.5% | +11.9% | -3.5% | |
| Dec 10, 2020 | HOLX Hologic Inc | Div. President, Diagnostics | Sale+OE | 16,869 | $73.99 | $1,248,212.42 | -33.7% | - | - | |
| May 15, 2020 | HOLX Hologic Inc | Div. President, Diagnostics | Sale+OE | 13,888 | $51.51 | $715,426.43 | -44.9% | - | - |